Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathology oncology research 2020-10, Vol.26 (4), p.2823-2825
Hauptverfasser:	Tsiambas, Evangelos, Papanikolaou, Vasileios, Chrysovergis, Aristeidis, Mastronikolis, Nicholas, Ragos, Vasileios, Kavantzas, Nikolaos, Lazaris, Andreas C., Kyrodimos, Efthymios
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE2 Angiotensin Angiotensin-Converting Enzyme 2 Betacoronavirus - genetics Betacoronavirus - pathogenicity Betacoronavirus - physiology Biomarkers Biomedical and Life Sciences Biomedicine Cancer Research Coronavirus Infections - complications Coronavirus Infections - genetics Coronavirus Infections - transmission Coronavirus Infections - virology Coronaviruses COVID-19 Hematologic Neoplasms - complications Hematologic Neoplasms - physiopathology Humans Immunocompromised Host Immunology Letter to the Editor Oncology Pandemics Pathology Peptidyl-dipeptidase A Peptidyl-Dipeptidase A - genetics Pneumonia, Viral - complications Pneumonia, Viral - genetics Pneumonia, Viral - transmission Pneumonia, Viral - virology Polymorphism, Single Nucleotide SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!